These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2684524)
1. Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease. Scigalla P; Bonzel KE; Bulla M; Burghard R; Dippel J; Geisert J; Leumann E; von Lilien T; Müller-Wiefel DE; Offner G Contrib Nephrol; 1989; 76():227-40; discussion 240-1. PubMed ID: 2684524 [No Abstract] [Full Text] [Related]
2. Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study. Pollok M; Bommer J; Gurland HJ; Koch KM; Schoeppe W; Scigalla P; Baldamus CA Contrib Nephrol; 1989; 76():201-11; discussion 212-8. PubMed ID: 2684523 [No Abstract] [Full Text] [Related]
3. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials. Sobota JT Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519 [No Abstract] [Full Text] [Related]
4. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO). Campos A; Garin EH Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282 [TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human erythropoietin treatment on renal anemia and body growth of children with end-stage renal disease. The European Multicenter Study Group. Scigalla P Contrib Nephrol; 1991; 88():201-11; discussion 212-4. PubMed ID: 2040184 [No Abstract] [Full Text] [Related]
7. Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy. Lerche D; Schmidt R; Zoellner K; Meier W; Paulitschke M; Distler B; Klinkmann H Contrib Nephrol; 1989; 76():299-303; discussion 304-5. PubMed ID: 2684529 [No Abstract] [Full Text] [Related]
8. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis. Korbet SM Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832 [No Abstract] [Full Text] [Related]
9. Effect of aluminum overload on the bone marrow response to recombinant human erythropoietin. Grützmacher P; Ehmer B; Messinger D; Kulbe KD; Scigalla P Contrib Nephrol; 1989; 76():315-21; discussion 322-3. PubMed ID: 2684530 [No Abstract] [Full Text] [Related]
10. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis. Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507 [TBL] [Abstract][Full Text] [Related]
12. USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients. Eschbach JW; Downing MR; Egrie JC; Browne JK; Adamson JW Contrib Nephrol; 1989; 76():160-5; discussion 212-8. PubMed ID: 2684518 [No Abstract] [Full Text] [Related]
13. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin. Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565 [TBL] [Abstract][Full Text] [Related]
14. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin. Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784 [No Abstract] [Full Text] [Related]
15. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159 [TBL] [Abstract][Full Text] [Related]
16. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment. Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170 [No Abstract] [Full Text] [Related]
17. Treatment of anaemia in chronic renal failure. Beer J Nurs Times; 1988 Nov 23-29; 84(47):55-7. PubMed ID: 3211795 [No Abstract] [Full Text] [Related]
18. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [TBL] [Abstract][Full Text] [Related]
19. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients. Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762 [TBL] [Abstract][Full Text] [Related]
20. Erythropoietin for anemia. Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624 [No Abstract] [Full Text] [Related] [Next] [New Search]